What is the recommended titration protocol and timing for epinephrine infusion, including initial dose, adjustment increments, and monitoring parameters?

Epinephrine Infusion Titration Protocol

For epinephrine infusion in shock states, start at 0.1-1.0 mcg/kg/min in adults (or 5-15 mcg/min absolute dosing), titrate upward based on clinical response to blood pressure and perfusion, with continuous hemodynamic monitoring mandatory. 1, 2

Initial Preparation and Dosing

Adults

• Standard concentration: 1 mg epinephrine in 250 mL D5W = 4 mcg/mL 3
• Alternative concentration (with infusion pump): 1 mg in 100 mL saline = 10 mcg/mL 3
• Starting rate:
  • Weight-based: 0.1-1.0 mcg/kg/min 1
  • Absolute dosing: 1-4 mcg/min (15-60 drops/min with microdrop apparatus) 3
  • Alternative: 30-100 mL/h (5-15 mcg/min) of the 1:100,000 solution 3, 4

Pediatrics

• Concentration: 0.6 × body weight (kg) = mg of epinephrine diluted to 100 mL saline; then 1 mL/h delivers 0.1 mcg/kg/min 3
• Starting rate: 0.1-1.0 mcg/kg/min 1
• Maximum: Up to 5 mcg/kg/min may be necessary in refractory shock 1

Titration Parameters

Titrate continuously based on:

• Mean arterial pressure (target restoration of adequate perfusion) 3, 2
• Heart rate and cardiac rhythm 3
• Oxygen saturation 5
• Clinical perfusion markers (mental status, urine output, skin perfusion)

Adjustment Increments

• Adults: Increase to maximum 10 mcg/min 3
• Pediatrics: Titrate up to 5 mcg/kg/min as needed 1
• Septic shock (FDA-approved): 0.05-2 mcg/kg/min range 2

Critical Monitoring Requirements

Continuous hemodynamic monitoring is essential when administering IV epinephrine infusions 3. This includes:

• Every-minute blood pressure measurements 3
• Continuous cardiac monitoring/ECG 3
• Pulse oximetry 5
• Urine output monitoring for oliguria/renal impairment 2

Context-Specific Indications

IV epinephrine infusion should only be used for:

1. Cardiac arrest 3
2. Profound hypotension unresponsive to volume replacement AND multiple IM epinephrine doses 3
3. Anaphylactic shock requiring continuous vasopressor support 4
4. Septic shock (FDA-approved indication) 2

Critical Safety Considerations

Potentially Lethal Arrhythmias

The risk of fatal arrhythmias is the primary reason IV epinephrine is restricted to severe cases 3. Do not use IV epinephrine as first-line treatment—intramuscular administration (0.01 mg/kg of 1:1000, max 0.3-0.5 mg) should be given first and repeated every 5-15 minutes 1, 4.

Extravasation Risk

IV infiltration causes severe skin necrosis 1, 2. Infuse into a large vein 2. If extravasation occurs, inject phentolamine 0.1-0.2 mg/kg (max 10 mg) diluted in 10 mL saline intradermally at the site 1.

Weaning Protocol

Wean gradually to avoid rebound hypotension 2. Do not abruptly discontinue.

Special Populations

Anaphylaxis-Specific Dosing

For anaphylaxis requiring continuous infusion after failed IM doses 5:

• Add 1 mg epinephrine to 1000 mL normal saline
• Start at 2 mcg/min (2 mL/min = 120 mL/h)
• Titrate up to 10 mcg/min (10 mL/min = 600 mL/h) 5

High-Risk Patients

Elderly patients, those with cardiovascular disease, and pregnant women require especially cautious titration 2. However, there is no absolute contraindication to epinephrine in life-threatening situations 3, 5.

Common Pitfalls

1. Using IV route prematurely: Always attempt IM epinephrine first in anaphylaxis 4
2. Inadequate monitoring: Never administer without continuous hemodynamic monitoring when available 3
3. Wrong concentration: Verify 1:10,000 (0.1 mg/mL) for IV use vs 1:1000 (1 mg/mL) for IM 1
4. Excessive dosing: Higher cumulative doses associated with worse neurological outcomes in cardiac arrest 5, 6, 7
5. Peripheral IV use: Increases extravasation risk—use large vein or central access when possible 2